Switch to:
More From Other Websites
AGENUS INC Files SEC form 8-K, Regulation FD Disclosure Feb 21 2017
​Lexington-based Agenus reworks Incyte pact, freeing up $80M in cash Feb 14 2017
Incyte and Agenus Amend Drug Licensing Deal Feb 14 2017
AGENUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Feb 14 2017
Incyte and Agenus Amend Collaboration Agreement Feb 14 2017
Agenus, Inc. – Value Analysis (NASDAQ:AGEN) : February 8, 2017 Feb 08 2017
Agenus, Inc. breached its 50 day moving average in a Bullish Manner : AGEN-US : February 7, 2017 Feb 07 2017
Agenus Appoints Jean-Marie Cuillerot, M.D. Chief Medical Officer Jan 30 2017
Agenus Inc (AGEN) Incorporates NCI In Evaluation Of Prophage-Keytruda Combo Jan 19 2017
Clinical Trial Hopes Drugs Help Body Fight Cancer Jan 18 2017
Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo Jan 18 2017
AGENUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 17 2017
Agenus announces collaboration with the National Cancer Institute to evaluate the combination of... Jan 17 2017
ETFs with exposure to Agenus, Inc. : January 6, 2017 Jan 06 2017
ETFs with exposure to Agenus, Inc. : December 21, 2016 Dec 21 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK